SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by First Light Asset Management LLC

First Light Asset Management LLC lowered its holdings in SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,136,982 shares of the company's stock after selling 389,233 shares during the period. SI-BONE comprises about 1.5% of First Light Asset Management LLC's portfolio, making the stock its 20th largest holding. First Light Asset Management LLC owned 2.71% of SI-BONE worth $15,940,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the company. Jane Street Group LLC lifted its stake in shares of SI-BONE by 29.0% during the 3rd quarter. Jane Street Group LLC now owns 77,359 shares of the company's stock worth $1,081,000 after buying an additional 17,410 shares during the last quarter. Barclays PLC grew its holdings in shares of SI-BONE by 190.8% during the 3rd quarter. Barclays PLC now owns 96,623 shares of the company's stock valued at $1,350,000 after purchasing an additional 63,402 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of SI-BONE by 3.4% during the 3rd quarter. Geode Capital Management LLC now owns 924,044 shares of the company's stock valued at $12,921,000 after purchasing an additional 30,005 shares during the last quarter. Franklin Resources Inc. boosted its position in SI-BONE by 9.4% during the 3rd quarter. Franklin Resources Inc. now owns 20,220 shares of the company's stock worth $265,000 after buying an additional 1,745 shares during the period. Finally, JPMorgan Chase & Co. raised its position in SI-BONE by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 177,793 shares of the company's stock worth $2,486,000 after purchasing an additional 22,732 shares during the last quarter. Institutional investors and hedge funds own 98.11% of the company's stock.

SI-BONE Price Performance

NASDAQ:SIBN traded down $0.63 during trading hours on Wednesday, hitting $13.65. 246,215 shares of the stock traded hands, compared to its average volume of 359,291. SI-BONE, Inc. has a 1 year low of $11.70 and a 1 year high of $19.16. The stock has a 50 day moving average price of $14.77 and a 200 day moving average price of $14.65. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The company has a market cap of $579.48 million, a price-to-earnings ratio of -14.84 and a beta of 1.02.

SI-BONE (NASDAQ:SIBN - Get Free Report) last announced its earnings results on Monday, February 24th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.05. The business had revenue of $49.00 million during the quarter, compared to analyst estimates of $48.87 million. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. Sell-side analysts forecast that SI-BONE, Inc. will post -0.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SIBN has been the subject of several research analyst reports. Cantor Fitzgerald reissued an "overweight" rating and issued a $25.00 price objective on shares of SI-BONE in a research report on Tuesday, February 25th. Truist Financial reissued a "buy" rating and set a $22.00 target price (up previously from $18.00) on shares of SI-BONE in a research report on Tuesday, February 25th. Finally, Needham & Company LLC boosted their target price on shares of SI-BONE from $20.00 to $24.00 and gave the company a "buy" rating in a report on Tuesday, February 25th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $24.40.

Insider Activity

In other SI-BONE news, insider Anthony J. Recupero sold 3,311 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.15, for a total transaction of $46,850.65. Following the transaction, the insider now owns 284,555 shares of the company's stock, valued at approximately $4,026,453.25. The trade was a 1.15 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Michael A. Pisetsky sold 3,128 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $14.14, for a total value of $44,229.92. Following the completion of the transaction, the senior vice president now directly owns 244,878 shares in the company, valued at approximately $3,462,574.92. This trade represents a 1.26 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,776 shares of company stock valued at $96,644 over the last ninety days. 3.90% of the stock is currently owned by insiders.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.